ANGIONI, MARIA MADDALENA
 Distribuzione geografica
Continente #
EU - Europa 40.641
NA - Nord America 1.125
AS - Asia 235
OC - Oceania 13
AF - Africa 6
Totale 42.020
Nazione #
IT - Italia 40.114
US - Stati Uniti d'America 1.114
DE - Germania 229
CN - Cina 114
SE - Svezia 107
UA - Ucraina 74
FI - Finlandia 35
GB - Regno Unito 30
VN - Vietnam 29
RU - Federazione Russa 25
HK - Hong Kong 18
SG - Singapore 15
AU - Australia 13
JP - Giappone 13
TR - Turchia 11
CA - Canada 10
IN - India 10
BE - Belgio 7
IR - Iran 7
LT - Lituania 6
EG - Egitto 4
KR - Corea 4
FR - Francia 3
ID - Indonesia 3
NL - Olanda 3
PL - Polonia 3
ES - Italia 2
PH - Filippine 2
PK - Pakistan 2
TW - Taiwan 2
ZA - Sudafrica 2
CH - Svizzera 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
MV - Maldive 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
SA - Arabia Saudita 1
Totale 42.020
Città #
Cagliari 39.985
Chandler 146
Fairfield 102
Houston 96
Nyköping 86
Woodbridge 75
Ann Arbor 67
Ashburn 62
Wilmington 54
Dearborn 53
Cambridge 51
Seattle 48
Jacksonville 38
Dong Ket 28
Boardman 25
Helsinki 24
Shanghai 24
Boston 20
Beijing 19
Hong Kong 18
New York 16
Nanjing 15
Rome 13
Milan 10
San Diego 9
Brisbane 8
London 8
Brussels 7
Changsha 7
Redwood City 7
Zola Predosa 7
Leawood 6
Los Angeles 6
Kocaeli 5
Nanchang 5
Norwalk 5
San Mateo 5
Sestu 5
Atlanta 4
Falls Church 4
Halifax 4
Kaunas 4
Kunming 4
Ningbo 4
Tianjin 4
Tokyo 4
Toronto 4
Amsterdam 3
Hefei 3
Jinan 3
Mountain View 3
Orange 3
Phoenix 3
San Sperate 3
Sassari 3
Selargius 3
Shenyang 3
Shimosakunobe 3
Verona 3
Zhengzhou 3
Alghero 2
Ardabil 2
Bangalore 2
Bochum 2
Bolu 2
Cairo 2
Chicago 2
Düsseldorf 2
El Escorial 2
Elmas 2
Faisalabad 2
Geelong 2
Genoa 2
Gold Coast 2
Guangzhou 2
Hebei 2
Huddersfield 2
Jiaxing 2
Kansas City 2
Mersin 2
Millbury 2
Mumbai 2
Nottingham 2
Otemae 2
Piemonte 2
Purbalingga 2
Singapore 2
Tertenìa 2
Usellus 2
Vilnius 2
Wroclaw 2
Xiamen 2
Acton 1
Agrinio 1
Ankara 1
Auburn Hills 1
Augusta 1
Austin 1
Bialystok 1
Borås 1
Totale 41.312
Nome #
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.364
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.261
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 2.896
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.676
NRF2 mutations are frequent in early rat preneoplastic hepatic lesions and in human hepatocellular carcinomas positive for the stem/progenitor cell marker KRT-19 2.536
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 2.464
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.460
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.413
Spa therapy induces clinical improvement and protein changes in patients with chronic back pain 1.904
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 1.900
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 1.874
Neonatal exposure to estradiol in rats influences neuroactive steroid concentrations, GABA(A) receptor expression, and behavioral sensitivity to anxiolytic drugs 1.778
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 1.746
La somministrazione neonatale di estrogeno modifica i livelli di steroidi neuroattivi, la plasticità dei recettori GABAA e la sensibilitò ai farmaci ansiolitici nelle femmine adulte 1.660
Changes in neuroactive steroids levels, GABAA receptor plasticity and sensitivity to anxiolytic drugs induced by neonatal exposure to estrogen 1.641
Changes in neuroactive steroid levels, GABAA receptor plasticity and sensitivity to anxiolytic drugs induced by neonatal exposure to estrogen 1.420
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 1.286
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 781
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 686
Response to treatment with chemical and biological inhibitors of c-met mutated form 607
Targeted Therapies in Axial Psoriatic Arthritis 587
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 512
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 354
SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS 343
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 337
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 302
GRAPPA 2020 Research Award Recipients 264
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 73
Totale 42.125
Categoria #
all - tutte 49.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019216 0 0 0 0 0 0 0 0 0 0 117 99
2019/20208.707 400 227 29 84 3.140 2.554 1.252 249 155 139 149 329
2020/202111.771 381 487 387 4.055 2.267 1.171 643 626 340 570 536 308
2021/20223.399 373 198 113 183 281 223 180 203 333 408 465 439
2022/20235.102 506 797 702 459 451 509 244 282 289 325 346 192
2023/20245.744 241 163 216 444 797 764 754 1.457 276 303 329 0
Totale 42.125